Ppar-Alpha in Lipid and Lipoprotein Metabolism, Vascular Inflammation and Atherosclerosis-Reference-Cited by-同舟云学术

Ppar-Alpha in Lipid and Lipoprotein Metabolism, Vascular Inflammation and Atherosclerosis

Published:2003 Issue: Volume: Page:3-16
ISSN:1389-1774
Container-title:Atherosclerosis, Hypertension and Diabetes
language:
Short-container-title:

Author:

Fruchart Jean-Charles,Staels Bart,Duriez Patrick

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-4419-9232-1_1

Reference61 articles.

1. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. 1995. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 333:1301–1307.

2. Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383–1389.

3. Sacks FM, Moye LA, Davis BR, Cole TG, Rouleau JL, Nash DT, Pfeffer MA, Braunwald E. 1998. Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial. Circulation 97:1446–1452.

4. Sprecher DL. 1998. Triglycerides as a risk factor for coronary artery disease. Am J Cardiol 82:49U–56U.

5. Saku K, Zhang B, Ohta T, Arakawa K. 1999. Quantity and function of high density lipoprotein as an indicator of coronary atherosclerosis. J Am Coll Cardiol 33:436–443.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pterostilbene: A Review on its Pharmacological Activities;Research Journal of Pharmacy and Technology;2023-11-30

2. Effect of pterostilbene on lipids and lipid profiles in streptozotocin-nicotinamide induced type 2 diabetes mellitus;Journal of Applied Biomedicine;2008-03-31

3. Identification of molecular pathways affected by pterostilbene, a natural dimethylether analog of resveratrol;BMC Medical Genomics;2008-03-20